A new method to help people with HIV quit smoking
A SMART Approach to Treating Tobacco Use Disorder in Persons Living with HIV
This study is looking at a new way to help people with HIV who want to quit smoking by trying different treatments based on how they respond, so if you're living with HIV and want to stop using tobacco, this research might be for you!
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10893629 on NIH RePORTER |
What this research studies
This research investigates a novel approach to treating tobacco use disorder specifically in individuals living with HIV. It utilizes a Sequential Multiple Assignment Randomized Trial (SMART) design, which allows for dynamic treatment adjustments based on individual responses to initial therapies. Participants will be assigned to receive either nicotine replacement therapy alone or combined with contingency management, with follow-up assessments to tailor ongoing treatment. The goal is to improve long-term smoking cessation outcomes for this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are living with HIV and currently smoke cigarettes.
Not a fit: Patients who do not smoke or are not living with HIV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance smoking cessation rates among individuals living with HIV, improving their overall health and quality of life.
How similar studies have performed: Previous studies have shown modest success in short-term smoking cessation among individuals with HIV, but this SMART approach is relatively novel and aims to address long-term outcomes more effectively.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Edelman, E. Jennifer — Yale University
- Study coordinator: Edelman, E. Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.